UNSPSC 51283612: Rifamycin sv

This classification denotes an antitubercular agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DU69T8ZZPA. European Medicines Agency schedules Rifamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10310MIG. Rifamycin generally arises in the molecular formula C37H47NO12.

The term RIFAMYCIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, list 5.) RIFAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule rifamycin sv under HS 29419000. SMILES: CC1C(C2C3C(CC(C2O)NC(=O)/C(=C\C=C\[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]([C@H](/C=C/O[C@@]4(C(=O)C3C1O4)C)OC)C)OC(=O)C)C)O)C)O)C)/C)O)O.

UNSPSC 51283612 Rifamycin sv is a Commodity code for a specific pharmaceutical active ingredient, but the recent state and local opportunities tagged under this code do not reflect purchases of rifamycin sv itself. Instead, the posted solicitations involve procurement of finished pharmaceutical products — antibiotics and overdose-reversal medications — through piggyback contracts and competitive bidding. State and local health departments and county health systems use this code's taxonomy to classify pharmaceutical supply chain activity, though the actual line items being purchased (Doxycycline Hyclate, Ciprofloxacin Hydrochloride, and Naloxone) fall under distinct commodity codes. Issuing bodies soliciting pharmaceutical supplies under related codes include state departments of public health and county health departments, typically as part of emergency preparedness, disease prevention, or community health initiatives.

The Illinois Department of Public Health awarded a piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, totaling $2,999,999.11 over the initial 12-month term plus two renewal years, for supply of two antibiotic products under an Invitation for Bid process. Seminole County, Florida posted a competitive bid on June 30, 2026 (though the due date shown in the source—July 26, 2023—appears to be a data error) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to its Community Health Building in Sanford. Recent activity centers in Illinois and Florida, with both opportunities emphasizing fixed-fee pricing, electronic submission through agency procurement portals, and compliance with drug-free workplace and E-Verify requirements. The code shows limited recent posting volume and a mismatch between the code's nominal scope and the products actually being solicited.